SK285200B6 - Použitie flunarizínu na zníženie očnej hypertenzie - Google Patents
Použitie flunarizínu na zníženie očnej hypertenzie Download PDFInfo
- Publication number
- SK285200B6 SK285200B6 SK499-2000A SK4992000A SK285200B6 SK 285200 B6 SK285200 B6 SK 285200B6 SK 4992000 A SK4992000 A SK 4992000A SK 285200 B6 SK285200 B6 SK 285200B6
- Authority
- SK
- Slovakia
- Prior art keywords
- flunarizine
- ophthalmic drug
- eye
- intraocular pressure
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Ophthalmology & Optometry (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT97RM000613A IT1295423B1 (it) | 1997-10-10 | 1997-10-10 | Uso della flunarizina nella terapia topica del glaucoma |
| PCT/IT1998/000266 WO1999018963A1 (en) | 1997-10-10 | 1998-10-06 | Use of flunarizine for the topical treatment of glaucoma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SK4992000A3 SK4992000A3 (en) | 2000-12-11 |
| SK285200B6 true SK285200B6 (sk) | 2006-08-03 |
Family
ID=11405290
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SK499-2000A SK285200B6 (sk) | 1997-10-10 | 1998-10-06 | Použitie flunarizínu na zníženie očnej hypertenzie |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US6380198B1 (pt) |
| EP (1) | EP1021184B1 (pt) |
| JP (1) | JP4475802B2 (pt) |
| AT (1) | ATE289198T1 (pt) |
| AU (1) | AU734137B2 (pt) |
| BR (1) | BR9813855A (pt) |
| CA (1) | CA2306371C (pt) |
| CZ (1) | CZ294314B6 (pt) |
| DE (1) | DE69829062T2 (pt) |
| ES (1) | ES2237852T3 (pt) |
| HU (1) | HU227940B1 (pt) |
| IT (1) | IT1295423B1 (pt) |
| PL (1) | PL192217B1 (pt) |
| PT (1) | PT1021184E (pt) |
| SK (1) | SK285200B6 (pt) |
| WO (1) | WO1999018963A1 (pt) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1252895A4 (en) * | 2000-01-31 | 2003-04-16 | Santen Pharmaceutical Co Ltd | REMEDIES FOR OPHTHALMIC DISORDERS |
| EP2319493A3 (en) * | 2002-07-23 | 2011-07-27 | Novartis AG | Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| CN101018546B (zh) * | 2004-09-10 | 2013-06-12 | 纽朗制药有限公司 | 作为钠和/或钙通道选择性调节剂的(卤代苄氧基)苄氨基-丙酰胺类 |
| SI1963280T1 (sl) | 2005-12-22 | 2016-02-29 | Newron Pharmaceuticals S.P.A. | 2-feniletilamino derivati kot modulatorji kalcijevih in/ali natrijevih kanalčkov |
| JP2009521493A (ja) * | 2005-12-23 | 2009-06-04 | アルコン，インコーポレイテッド | 眼への受容体チロシンキナーゼ阻害（ＲＴＫｉ）化合物の送達のための医薬製剤 |
| PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| TWI544922B (zh) | 2011-05-19 | 2016-08-11 | 愛爾康研究有限公司 | 高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物 |
| PL2723710T3 (pl) | 2011-06-27 | 2017-02-28 | Newron Pharmaceuticals S.P.A. | Fluorowane pochodne aryloalkiloaminokarboksyamidowe |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4246793A (en) * | 1992-05-13 | 1993-12-13 | Alcon Laboratories, Inc. | Topical ophthalmic compositions comprising a combination of calcium antagonists with known antiglaucoma agents |
-
1997
- 1997-10-10 IT IT97RM000613A patent/IT1295423B1/it active IP Right Grant
-
1998
- 1998-10-06 US US09/509,912 patent/US6380198B1/en not_active Expired - Lifetime
- 1998-10-06 WO PCT/IT1998/000266 patent/WO1999018963A1/en active IP Right Grant
- 1998-10-06 SK SK499-2000A patent/SK285200B6/sk not_active IP Right Cessation
- 1998-10-06 AU AU96433/98A patent/AU734137B2/en not_active Ceased
- 1998-10-06 BR BR9813855-3A patent/BR9813855A/pt not_active Application Discontinuation
- 1998-10-06 CA CA002306371A patent/CA2306371C/en not_active Expired - Fee Related
- 1998-10-06 DE DE69829062T patent/DE69829062T2/de not_active Expired - Lifetime
- 1998-10-06 CZ CZ20001213A patent/CZ294314B6/cs not_active IP Right Cessation
- 1998-10-06 ES ES98950292T patent/ES2237852T3/es not_active Expired - Lifetime
- 1998-10-06 PL PL339453A patent/PL192217B1/pl unknown
- 1998-10-06 AT AT98950292T patent/ATE289198T1/de active
- 1998-10-06 JP JP2000515598A patent/JP4475802B2/ja not_active Expired - Fee Related
- 1998-10-06 PT PT98950292T patent/PT1021184E/pt unknown
- 1998-10-06 EP EP98950292A patent/EP1021184B1/en not_active Expired - Lifetime
- 1998-10-06 HU HU0003803A patent/HU227940B1/hu not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CZ20001213A3 (cs) | 2000-07-12 |
| ES2237852T3 (es) | 2005-08-01 |
| HUP0003803A2 (hu) | 2001-05-28 |
| PL339453A1 (en) | 2000-12-18 |
| AU734137B2 (en) | 2001-06-07 |
| CA2306371A1 (en) | 1999-04-22 |
| PL192217B1 (pl) | 2006-09-29 |
| WO1999018963A1 (en) | 1999-04-22 |
| HU227940B1 (hu) | 2012-06-28 |
| HUP0003803A3 (en) | 2001-12-28 |
| DE69829062T2 (de) | 2006-02-09 |
| SK4992000A3 (en) | 2000-12-11 |
| CZ294314B6 (cs) | 2004-11-10 |
| JP2001519394A (ja) | 2001-10-23 |
| PT1021184E (pt) | 2005-06-30 |
| DE69829062D1 (de) | 2005-03-24 |
| EP1021184B1 (en) | 2005-02-16 |
| IT1295423B1 (it) | 1999-05-12 |
| ITRM970613A1 (it) | 1999-04-10 |
| BR9813855A (pt) | 2000-09-19 |
| JP4475802B2 (ja) | 2010-06-09 |
| US6380198B1 (en) | 2002-04-30 |
| ATE289198T1 (de) | 2005-03-15 |
| AU9643398A (en) | 1999-05-03 |
| EP1021184A1 (en) | 2000-07-26 |
| CA2306371C (en) | 2008-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baudouin | Detrimental effect of preservatives in eyedrops: implications for the treatment of glaucoma | |
| KR20080011310A (ko) | 폴록사머 또는 메록사폴 계면활성제 및 글리콜을유효성분으로 함유하는 현탁제, 안질환 치료용 의약의제조를 위한 그의 용도 | |
| KR20080011311A (ko) | 안과 약제, 폴록사민 및 글리콜 장성―조절제를 포함하는안과 현탁제, 안질환 치료용 의약의 제조를 위한 상기조성물의 용도 | |
| CA2840734A1 (en) | Macrogol 15 hydroxystearate formulations | |
| Maślanka | A review of the pharmacology of carbonic anhydrase inhibitors for the treatment of glaucoma in dogs and cats | |
| WO1989010757A1 (en) | New ophthalmic preparation for treating glaucoma | |
| AU636685B2 (en) | Compositions of antiallergics and antihistamines and methods for their use | |
| US6476039B1 (en) | Ophthalmic composition | |
| AU704938B2 (en) | Combination therapy for treating glaucoma | |
| SK285200B6 (sk) | Použitie flunarizínu na zníženie očnej hypertenzie | |
| EP1283043A1 (en) | Ophthalmic solution | |
| US20030007971A1 (en) | Remedies for ophthalmic diseases | |
| ASHTON et al. | The effect of chlorhexidine acetate on the corneal penetration of sorbitol from an arnolol formulation in the albino rabbit | |
| EP3730137B1 (en) | Therapeutic agent for glaucoma comprising an fp agonist and timolol | |
| RU2434633C2 (ru) | Фармацевтические препаративные формы латрункулина | |
| EP0728480A1 (en) | Use of ifenprodil for treatment of elevated intraocular pressure | |
| EP1252895A1 (en) | Remedies for ophthalmic diseases | |
| Plummer | Part 5: Medical Therapy for Glaucoma | |
| US6248759B1 (en) | Method for treatment of light-injured retinal degeneration disease | |
| Burstein | Basic Science of Ocular | |
| US20150174122A1 (en) | Methods for treating eye disorders using opioid receptor antagonists |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20151006 |